Chesapeake Clinical Research, Inc.

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Asthma9 trials
• Chronic rhinosinusitis with nasal polyps2 trials
• Atopic dermatitis (eczema)1 trial
• Chronic spontaneous urticaria1 trial
• COPD1 trial

Phase

• Phase 27 trials
• Phase 35 trials
• Phase 11 trial

Status

• Completed7 trials
• Active, not recruiting4 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Upstream Bio Inc.4 trials
• Pfizer2 trials
• Teva Branded Pharmaceutical Products R&D LLC2 trials
• Amgen1 trial
• Connect Biopharm LLC1 trial
• and 4 more

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma

  NCT07772921· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

  NCT06981078· Phase 2· Upstream Bio Inc.· Source

• Active, not recruiting

  A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

  NCT06966479· Phase 2· Upstream Bio Inc.· Source

• Active, not recruiting

  A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

  NCT06637371· Phase 1· Amgen· Source

• Recruiting

  A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

  NCT06338995· Phase 3· Eli Lilly and Company· Source

  Contact: Sudhir Sekhsaria (principal investigator)

• Active, not recruiting

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting
• Chronic rhinosinusitis with nasal polyps1 recruiting

Closed trials

• Completed

  Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

  NCT06940141· Phase 2· Connect Biopharm LLC· Source

• Completed

  A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  NCT06664619· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source

• Completed

  A Study to Evaluate Solriktug in Adult Participants With Asthma

  NCT06496607· Phase 2· Uniquity One (UNI)· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Upstream Bio Inc.· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

  NCT06164704· Phase 2· Upstream Bio Inc.· Source

• Terminated

  Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

  NCT06077773· Phase 2· Escient Pharmaceuticals, Inc· Source

• Completed

  Registry of Asthma Patients Initiating DUPIXENT®

  NCT04287621· Regeneron Pharmaceuticals· Source

• Completed

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· Phase 3· Pfizer· Source